SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-22-014780
Filing Date
2022-01-21
Accepted
2022-01-21 16:01:15
Documents
1
Group Members
ATP III GP, LTD.SETH L. HARRISON

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d296216dsc13ga.htm SC 13G/A 55544
  Complete submission text file 0001193125-22-014780.txt   57386
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Subject) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88812 | Film No.: 22545914
SIC: 2834 Pharmaceutical Preparations

Mailing Address 230 PARK AVENUE, SUITE 2800 NEW YORK NY 10169
Business Address 230 PARK AVENUE, SUITE 2800 NEW YORK NY 10169 212-468-5800
ATP Life Science Ventures, L.P. (Filed by) CIK: 0001593440 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A